Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +44.37%
#2 Bitway Bitway +38.72%
#3 Pons Pons +35.79%
#4 Starpower Starpower +33.84%
#5 Mubarak Mubarak +32.84%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#7 Ocean Protocol Ocean Protocol +27.09%
#8 SkyAI SkyAI +25.60%
#9 StonkBroker StonkBroker +19.21%
#10 PondCoin PondCoin +18.51%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
Classifica tra le azioni #29238
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Prezzo delle azioni
$0.31640033
Capitalizzazione di mercato
$22.25M
Variazione (1 giorno)
-3.40%
Variazione (1 anno)
-36.80%
Paese
TW
Scambia General Biologicals Corporation (4117)

Categoria

Healthcare
Ricavi di General Biologicals Corporation (4117)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di General Biologicals Corporation, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per General Biologicals Corporation da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
STERIS plc STERIS plc
STERIS plc
STE.US
 $6.04B -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
 - -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
 - -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
 - -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
 - -
CN